Home » BioMérieux Wins FDA Clearance
BioMérieux Wins FDA Clearance
July 1, 2016
BioMérieux has won FDA clearance for the expanded use of its Vidas BRAHMS PCT assay, which is intended for managing sepsis in patients with an increased risk of mortality.
The clearance will allow the company to use the change in PCT levels over time to facilitate management of sepsis patients after the initial diagnosis. — Anisa Jibrell
Upcoming Events
-
21Oct